Menin-MLL inhibitor 19
Modify Date: 2024-01-03 10:06:20
Menin-MLL inhibitor 19 structure
|
Common Name | Menin-MLL inhibitor 19 | ||
|---|---|---|---|---|
| CAS Number | 2360487-93-8 | Molecular Weight | 645.70 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H34F3N7O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Menin-MLL inhibitor 19Menin-MLL inhibitor 19, a potent exo-aza spiro inhibitor of menin-mll interaction, example A17, extracted from patent WO2019120209A1. Menin-MLL inhibitor 19 can be used for the reseaech of various diseases, such as cancer, myelodysplastic syndrome (MDS) and diabetes[1]. |
| Name | Menin-MLL inhibitor 19 |
|---|
| Description | Menin-MLL inhibitor 19, a potent exo-aza spiro inhibitor of menin-mll interaction, example A17, extracted from patent WO2019120209A1. Menin-MLL inhibitor 19 can be used for the reseaech of various diseases, such as cancer, myelodysplastic syndrome (MDS) and diabetes[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: menin-mll interaction[1] |
| References |
[1]. Xuedong Dai, et al. Exo-aza spiro inhibitors of menin-mll interaction. Patent WO2019120209A1 |
| Molecular Formula | C30H34F3N7O4S |
|---|---|
| Molecular Weight | 645.70 |